Novo Nordisk, Inc. et al v. Viatris Inc. et al
Novo Nordisk, Inc. and Novo Nordisk A/S |
Viatris Inc. and Mylan Pharmaceuticals Inc. |
1:2023cv00013 |
January 27, 2023 |
US District Court for the Northern District of West Virginia |
Thomas S Kleeh |
Patent |
35 U.S.C. § 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on February 17, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
|
|
|
|
|
|
|
|
Filing 15 WAIVER OF SERVICE Returned Executed by Novo Nordisk, Inc., Novo Nordisk A/S. All Defendants. (Companion, James) |
Filing 14 Pro Hac Vice filing fees for N. Groombridge, J. Wu, J. Reich, J. Young, D. Klein, N. Wehrli, P. Sandel, and S. Miller received in the amount of $1600.00, receipt number WVNC003597. (hrc) |
Filing 13 MOTION for Leave to Appear Pro Hac Vice of Scott E. Miller by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) |
Filing 12 MOTION for Leave to Appear Pro Hac Vice of Peter Sandel by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) |
Filing 11 MOTION for Leave to Appear Pro Hac Vice of Naz E. Wehrli by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) |
Filing 10 MOTION for Leave to Appear Pro Hac Vice of Daniel J. Klein by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) |
Filing 9 MOTION for Leave to Appear Pro Hac Vice of Josephine Young by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) |
Filing 8 MOTION for Leave to Appear Pro Hac Vice of Joshua Reich by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) |
Filing 7 MOTION for Leave to Appear Pro Hac Vice of Jenny C. Wu by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) |
Filing 6 MOTION for Leave to Appear Pro Hac Vice of Nicholas Groombridge by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) |
Filing 5 VERIFICATION OF ATTORNEY ADMISSION to Attorneys N. Groombridge, P. Sandel, D. Klein, J. Wu, J. Reich, N. Wehrli, and J. Young. (dk) |
Filing 4 REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (dk) |
Filing 3 PLAINTIFFS' FED.R.CIV.P. 7.1 STATEMENT by Novo Nordisk A/S, Novo Nordisk, Inc. (dk) |
Filing 2 SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG APPLICATION (ANDA) filed by Novo Nordisk A/S, Novo Nordisk, Inc. (dk) |
Filing 1 COMPLAINT against Mylan Pharmaceuticals Inc., Viatris Inc., filed by Novo Nordisk, Inc., Novo Nordisk A/S. Filing Fee Paid $402. Receipt #AWVNDC-3636472. (Attachments: #1 Exhibit 1 - Patent No. US 8,129,343 B2, #2 Exhibit 2 - Patent No. US 8,536,122 B2, #3 Exhibit 3 - Patent No. US 9,764,003 B2, #4 Exhibit 4 - Patent No. US 10,888,605 B2, #5 Exhibit 5 - Patent No. US 11,318,191 B2, #6 Civil Cover Sheet)(dk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.